These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liver-Directed AAV8 Booster Vaccine Expressing Plasmodium falciparum Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model. Shahnaij M, Iyori M, Mizukami H, Kajino M, Yamagoshi I, Syafira I, Yusuf Y, Fujiwara K, Yamamoto DS, Kato H, Ohno N, Yoshida S. Front Immunol; 2021; 12():612910. PubMed ID: 34248928 [Abstract] [Full Text] [Related]
3. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites. Atre T, Robinson TM, Savransky T, Dutta S, Epstein JE, Bergmann-Leitner ES. Malar J; 2019 May 29; 18(1):186. PubMed ID: 31142328 [Abstract] [Full Text] [Related]
4. Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection. Gibbins MP, Müller K, Glover M, Liu J, Putrianti ED, Bauza K, Reyes-Sandoval A, Matuschewski K, Silvie O, Hafalla JCR. Infect Immun; 2020 Sep 18; 88(10):. PubMed ID: 32719159 [Abstract] [Full Text] [Related]
8. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice. Vom Steeg LG, Flores-Garcia Y, Zavala F, Klein SL. Vaccine; 2019 Jul 26; 37(32):4468-4476. PubMed ID: 31262583 [Abstract] [Full Text] [Related]
12. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH. J Infect Dis; 2007 Aug 15; 196(4):608-16. PubMed ID: 17624848 [Abstract] [Full Text] [Related]
13. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Behet MC, Foquet L, van Gemert GJ, Bijker EM, Meuleman P, Leroux-Roels G, Hermsen CC, Scholzen A, Sauerwein RW. Malar J; 2014 Apr 05; 13():136. PubMed ID: 24708526 [Abstract] [Full Text] [Related]
16. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T, Ploemen IH, van Schaijk BC, Sajid M, Vos MW, van Gemert GJ, Chevalley-Maurel S, Franke-Fayard BM, Hermsen CC, Gego A, Franetich JF, Mazier D, Hoffman SL, Janse CJ, Sauerwein RW, Khan SM. Vaccine; 2012 Mar 30; 30(16):2662-70. PubMed ID: 22342550 [Abstract] [Full Text] [Related]
17. The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria. Itsara LS, Zhou Y, Do J, Grieser AM, Vaughan AM, Ghosh AK. Front Immunol; 2018 Mar 30; 9():2748. PubMed ID: 30619241 [Abstract] [Full Text] [Related]